Bank Of New York Mellon Corp Tenaya Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$1.68 - $3.19 $127,579 - $242,248	75,940 New	75,940 $152,000
Q3 2022 Nov 14, 2022	BUY	$2.9 - $5.88 $21,868 - $44,341	7,541 Added 11.03%	75,940 $220,000
Q2 2022 Aug 15, 2022	SELL	$5.01 - $14.12 $24,624 - $69,399	-4,915 Reduced 6.7%	68,399 $385,000
Q1 2022 May 11, 2022	BUY	$9.41 - $19.3 $317,361 - $650,911	33,726 Added 85.19%	73,314 $864,000
Q4 2021 Feb 11, 2022	BUY	$18.41 - $29.58 $94,019 - $151,065	5,107 Added 14.81%	39,588 $750,000
Q3 2021 Nov 12, 2021	BUY	$15.35 - $26.66 $529,283 - $919,263	34,481 New	34,481 $712,000

56.3M

900

400

Ticker TNYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,364,700
Market Cap $136M
Description
Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.